Bionime Corporation (TPE:4737)
Taiwan · Delayed Price · Currency is TWD 53.70
-0.30 (-0.56%)
Jan 22, 2026, 1:35 PM CST
Bionime Market Cap
Bionime has a market cap or net worth of 3.63 billion as of January 21, 2026. Its market cap has decreased by -8.81% in one year.
Market Cap
3.63B
Enterprise Value
6.24B
Revenue
1.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
53.70
Market Cap Chart
Since September 3, 2009, Bionime's market cap has increased from 2.06B to 3.63B, an increase of 76.08%. That is a compound annual growth rate of 3.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 3.63B | -9.24% |
| Dec 31, 2025 | 4.00B | 1.37% |
| Dec 31, 2024 | 3.95B | -13.19% |
| Dec 29, 2023 | 4.55B | -2.90% |
| Dec 30, 2022 | 4.69B | 2.61% |
| Dec 30, 2021 | 4.57B | 12.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioteque | 8.32B |
| Pacific Hospital Supply | 6.03B |
| Formosa Optical Technology | 5.99B |
| St.Shine Optical | 5.87B |
| SciVision Biotech | 5.79B |
| ICARES Medicus | 3.98B |
| Maxigen Biotech | 3.75B |
| Nang Kuang Pharmaceutical | 3.69B |